Company intelligence / Profile preview
Vaxess Technologies
Cambridge, Massachusetts, United Statesvaxess.com ↗
- Ownership
- Private
- Employees
- ~42
- Development stage
- Phase 1
01
Overview
Vaxess Technologies has developed the MIMIX™ microneedle patch platform enabling shelf-stable, needle-free transdermal delivery of vaccines and therapeutics. The lead program—a flu vaccine delivered by the MIMIX MAP—has reached Phase I clinical trials. Preclinical data show enhanced immune responses compared to traditional vaccines, including broader protection against drifted strains. The company’s technology eliminates cold chain requirements and enables self-administration at home or in low-resource settings. Additional pipeline programs target infectious diseases, metabolic disorders with GLP‑1 analogs, mRNA-based therapies, and cancer immunotherapy.
- Therapeutic areas
- Metabolic DisordersOncologyInfectious Diseases
- Modalities
- Vaccines (including mRNA and virus-like particles)Biologics (e.g., GLP‑1 analogs)ImmunotherapiesMicroneedle/Transdermal delivery systems (MIMIX patch)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
AstraZeneca ($10M+ partnership on development of microneedle-delivered vaccines)Medigen Vaccine Biologics Co.multiple pharmaceutical companies in joint development partnershipsfunding from BARDA/DARPA/Gates Foundation/NIAID/NIH/NSF
Beyond the preview
Go deeper on Vaxess Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vaxess Technologies.